PubMed:33048372 / 727-884 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":39,"end":42},"obj":"Disease"},{"id":"T9","span":{"begin":94,"end":97},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0019124"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0019124"}],"text":"1) tacrolimus (Tac)+mycophenolic acid (MPA)+prednisone (Pred) (referent group, 77.7%); 2) Tac+MPA+Pred+HCQ (16.5%); or 3) other immunosuppression+HCQ (5.7%)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":3,"end":13},"obj":"Chemical"},{"id":"T7","span":{"begin":15,"end":18},"obj":"Chemical"},{"id":"T8","span":{"begin":20,"end":37},"obj":"Chemical"},{"id":"T9","span":{"begin":33,"end":37},"obj":"Chemical"},{"id":"T10","span":{"begin":39,"end":42},"obj":"Chemical"},{"id":"T13","span":{"begin":44,"end":54},"obj":"Chemical"},{"id":"T14","span":{"begin":56,"end":60},"obj":"Chemical"},{"id":"T15","span":{"begin":72,"end":77},"obj":"Chemical"},{"id":"T16","span":{"begin":90,"end":93},"obj":"Chemical"},{"id":"T17","span":{"begin":94,"end":97},"obj":"Chemical"},{"id":"T20","span":{"begin":98,"end":102},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_61049"},{"id":"A6","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_61057"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_61049"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_168396"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_6716"},{"id":"A11","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_138016"},{"id":"A12","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_168396"},{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_8382"},{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_8382"},{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_61049"},{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_6716"},{"id":"A18","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_138016"},{"id":"A19","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_168396"},{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_8382"}],"text":"1) tacrolimus (Tac)+mycophenolic acid (MPA)+prednisone (Pred) (referent group, 77.7%); 2) Tac+MPA+Pred+HCQ (16.5%); or 3) other immunosuppression+HCQ (5.7%)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"47","span":{"begin":3,"end":13},"obj":"Chemical"},{"id":"48","span":{"begin":15,"end":18},"obj":"Chemical"},{"id":"49","span":{"begin":20,"end":37},"obj":"Chemical"},{"id":"50","span":{"begin":39,"end":42},"obj":"Chemical"},{"id":"51","span":{"begin":44,"end":54},"obj":"Chemical"},{"id":"52","span":{"begin":56,"end":60},"obj":"Chemical"},{"id":"53","span":{"begin":90,"end":93},"obj":"Chemical"},{"id":"54","span":{"begin":94,"end":97},"obj":"Chemical"},{"id":"55","span":{"begin":98,"end":102},"obj":"Chemical"},{"id":"56","span":{"begin":103,"end":106},"obj":"Chemical"},{"id":"57","span":{"begin":146,"end":149},"obj":"Chemical"}],"attributes":[{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"MESH:D016559"},{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"MESH:D016559"},{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"MESH:D009173"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"MESH:D009173"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"MESH:D011241"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"MESH:D011241"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"MESH:D016559"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"MESH:D009173"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"MESH:D011241"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"MESH:D006886"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"1) tacrolimus (Tac)+mycophenolic acid (MPA)+prednisone (Pred) (referent group, 77.7%); 2) Tac+MPA+Pred+HCQ (16.5%); or 3) other immunosuppression+HCQ (5.7%)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":0,"end":157},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"1) tacrolimus (Tac)+mycophenolic acid (MPA)+prednisone (Pred) (referent group, 77.7%); 2) Tac+MPA+Pred+HCQ (16.5%); or 3) other immunosuppression+HCQ (5.7%)."}